Sweden ADHD autism inquiry will examine why more children and young people are being diagnosed with ADHD and autism, as the government moves to assess both the rise in diagnoses and the support available in schools, healthcare, social services, leisure activities and the transition to work.
The Swedish government announced the new delegation on 3 July 2026. It will be led by Mathias Wahlsten, Director General of the Swedish Unemployment Insurance Inspectorate (Inspektionen för arbetslöshetsförsäkringen, IAF), and must report its findings by 1 December 2027.
The inquiry comes amid a sharp increase in neuropsychiatric diagnoses among children and young people, particularly ADHD and autism. For Sweden, the issue is no longer limited to healthcare capacity. It also concerns how schools, municipalities, social services and employers respond to young people who need support, with or without a formal diagnosis.
Why Sweden is opening an ADHD and autism inquiry
The government says the delegation will analyse the factors behind the rise in ADHD and autism diagnoses among children and young people. It will also assess the consequences for healthcare, social services and the education system.
Minister for Social Affairs (Socialminister) Jakob Forssmed said Sweden needs a clearer picture of what is driving the trend. “When more children and young people receive a neuropsychiatric diagnosis, we need a comprehensive picture of what drives this development,” he said.
The delegation will not only study the increase in diagnoses. It will also propose measures to improve support for children and young people with neuropsychiatric disabilities (neuropsykiatriska funktionsnedsättningar, NPF) and their families.
According to the government, the aim is to strengthen society’s ability to provide good and equal living conditions, participation and security for young people with NPF diagnoses across the country.
Minister for Social Services (Socialtjänstminister) Camilla Waltersson Grönvall said a diagnosis should not determine a child’s opportunities in life. The government also pointed to delays in support, especially in schools, where many pupils receive help too late.
ADHD diagnoses have risen sharply in Sweden
The rise in ADHD diagnoses has already been documented by Sweden’s National Board of Health and Welfare (Socialstyrelsen). In 2023, the agency reported that ADHD and ADD diagnoses among school-age children had increased strongly, with particularly rapid growth among girls aged 10–17 and young women aged 18–24.
Socialstyrelsen estimated that 10.5 percent of boys and 6 percent of girls aged 10–17 had an ADHD or ADD diagnosis. It also warned that, if trends continued, the share could eventually rise to 15 percent among boys and 11 percent among girls before levelling off.
The agency linked prescription data and patient records to estimate diagnosis levels. It noted that about three quarters of schoolchildren aged 10–17 start medication after receiving an ADHD diagnosis.
The increase has raised difficult questions. Part of the trend may reflect better recognition, especially among girls and young women who were historically less likely to be diagnosed. But the scale of the rise has also intensified debate over school environments, diagnostic thresholds, regional differences and the relationship between diagnosis and access to support.
Socialstyrelsen has also reported significant regional variation. In some regions, the proportion of children receiving ADHD medication is much higher than in others, suggesting that access, clinical practice and local systems may influence the likelihood of diagnosis.
Autism diagnoses are also increasing
Autism diagnoses have also increased in Sweden. The OECD noted in 2026 that Sweden does not have a population-level survey measuring autism prevalence directly. Instead, the country relies on health system data from the national patient register.
According to the OECD, diagnoses recorded in inpatient and specialised outpatient care show that the rate of autism among children increased four- to fivefold between 2008 and 2024. The organisation also noted that the gender gap has narrowed, especially among older children and young people.
In 2010, boys aged 10–17 were more than twice as likely as girls to receive a new autism diagnosis. By 2023, new diagnoses among girls in that age group had almost caught up with boys. Among 18–24-year-olds, young women received more new autism diagnoses than men from 2020 onwards.
This development has changed the public debate. For many experts, the increase may partly reflect improved knowledge of how autism can appear differently among girls and women. At the same time, it raises questions about whether services are prepared to provide support once more people are identified.
Support should not wait for a diagnosis
Sweden has already moved in this direction through national guidelines. In 2024, Socialstyrelsen published updated national guidelines for ADHD and autism, aimed at decision-makers in healthcare, student health services and social services.
A central message was that early support should be offered without waiting for a diagnosis, while neuropsychiatric assessments should not be unnecessarily delayed. The guidelines also called for stronger knowledge among healthcare and social service staff, and better support for vulnerable groups.
This is a key issue for the new delegation. In practice, many families seek a diagnosis because it can unlock access to school adaptations, healthcare pathways or social support. If support depends too heavily on formal diagnosis, waiting lists can grow and families may face long periods without help.
The government’s inquiry will therefore have to address a structural question: how Sweden can provide timely support while also ensuring that diagnoses remain clinically meaningful and consistently applied.
Schools are central to the Swedish NPF debate
Schools are likely to be one of the main areas examined by the delegation. In March 2026, the Swedish Parliament’s Committee on Education presented a report on schooling and academic outcomes for pupils with ADHD and autism.
According to the report, pupils with ADHD and/or autism make up 13.5 percent of the overall student population. They achieve lower grades and lower eligibility for upper-secondary education than other pupils, although the report also found that they can succeed when the right support is provided.
Sven Bölte, professor of child and adolescent psychiatric science at Karolinska Institutet, told the committee that many schools still do not offer sufficiently inclusive education. He argued that policy recommendations often refer to interventions that schools cannot realistically access without better conditions and coordination.
This points to a broader challenge in the Nordic welfare model. Sweden has strong public institutions and a high level of administrative capacity, but families can still experience fragmented support between schools, healthcare, social services and labour-market institutions.
A wider Nordic and European issue
Sweden is not alone in facing rising ADHD and autism diagnoses. Other high-income countries have also reported increases, especially among children, adolescents and young adults. The causes remain debated and likely include several overlapping factors: greater awareness, changing diagnostic practices, school and workplace demands, mental health pressures and improved recognition among girls and women.
The Swedish inquiry could therefore become relevant beyond Sweden. Nordic countries often present themselves as systems where early intervention, universal welfare and inclusive education reduce long-term social exclusion. Rising NPF diagnoses test that model in a practical way.
If Sweden can design support that does not depend excessively on formal diagnosis, it may offer lessons for other European countries. If it fails, the result could be longer waiting times, unequal access and growing pressure on families, schools and healthcare providers.
The delegation’s report, due by 1 December 2027, will not settle the medical debate on ADHD and autism. But it may shape how Sweden understands the social consequences of the diagnosis boom, and whether its welfare institutions can adapt before the pressure becomes harder to manage.
